Center-Authored Papers

Filters: Author is Storb, R  [Clear All Filters]
1988
Schuening F, Storb R, Nash R, Stead RB, Kwok WW, Miller AD.  1988.  Retroviral transfer of genes into canine hematopoietic progenitor cells.. Advances in experimental medicine and biology. 241:9-18. Abstract
Stead RB, Kwok WW, Storb R, Miller AD.  1988.  Canine model for gene therapy: inefficient gene expression in dogs reconstituted with autologous marrow infected with retroviral vectors.. Blood. 71(3):742-7. Abstract
1989
Schuening FG, Storb R, Stead RB, Goehle S, Nash R, Miller AD.  1989.  Improved retroviral transfer of genes into canine hematopoietic progenitor cells kept in long-term marrow culture.. Blood. 74(1):152-5. Abstract
1990
Flowers ME, Stockschlaeder MA, Schuening FG, Niederwieser D, Hackman R, Miller AD, Storb R.  1990.  Long-term transplantation of canine keratinocytes made resistant to G418 through retrovirus-mediated gene transfer.. Proceedings of the National Academy of Sciences of the United States of America. 87(6):2349-53. Abstract
1991
Stockschlaeder MA, Storb R, Osborne WR, Miller AD.  1991.  L-histidinol provides effective selection of retrovirus-vector-transduced keratinocytes without impairing their proliferative potential.. Human gene therapy. 2(1):33-9. Abstract
1992
Appelbaum FR, Badger CC, Bernstein ID, Buckner CD, Deeg HJ, Eary JF, Matthews DC, Press OW, Storb R, Thomas ED.  1992.  Is there a better way to deliver total body irradiation? Bone marrow transplantation. 10 Suppl 1:77-81. Abstract
1994
Schuening F, Miller AD, Torok-Storb B, Bensinger W, Storb R, Reynolds T, Fisher L, Buckner CD, Appelbaum FR.  1994.  Study on contribution of genetically marked peripheral blood repopulating cells to hematopoietic reconstitution after transplantation.. Human gene therapy. 5(12):1523-34.
1996
Kiem HP, Darovsky B, von Kalle C, Goehle S, Graham T, Miller AD, Storb R, Schuening FG.  1996.  Long-term persistence of canine hematopoietic cells genetically marked by retrovirus vectors.. Human gene therapy. 7(1):89-96. Abstract
Brunvand MW, Bensinger WI, Soll E, Weaver CH, Rowley SD, Appelbaum FR, Lilleby K, Clift RA, Gooley TA, Press OW et al..  1996.  High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.. Bone marrow transplantation. 18(1):131-41. Abstract
1997
Schuening F, Longo WL, Atkinson ME, Zaboikin M, Kiem HP, Sanders J, Scott CR, Storb R, Miller AD, Reynolds T et al..  1997.  Retrovirus-mediated transfer of the cDNA for human glucocerebrosidase into peripheral blood repopulating cells of patients with Gaucher's disease.. Human gene therapy. 8(17):2143-60.
1999
Matthews DC, Appelbaum FR, Eary JF, Fisher DR, Durack LD, Hui TE, Martin PJ, Mitchell D, Press OW, Storb R et al..  1999.  Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome.. Blood. 94(4):1237-47. Abstract
Kiem HP, McSweeney PA, Bruno B, Goerner M, Buron G, Morris J, Storb R, Miller AD.  1999.  Improved gene transfer into canine hematopoietic repopulating cells using CD34-enriched marrow cells in combination with a gibbon ape leukemia virus-pseudotype retroviral vector.. Gene therapy. 6(6):966-72. Abstract
Mielcarek M, Bryant E, Loken M, Torok-Storb B, Storb R.  1999.  Haemopoietic reconstitution by donor-derived myelodysplastic progenitor cells after haemopoietic stem cell transplantation.. British journal of haematology. 105(2):361-5. Abstract
2000
Mielcarek M, Leisenring W, Torok-Storb B, Storb R.  2000.  Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect.. Blood. 96(3):1150-6. Abstract
2002
Maciej Zaucha J, Mielcarek M, Takatu A, Little M-T, Gooley T, Baker J, Maloney DG, Sandmaier BM, Maris M, Chauncey T et al..  2002.  Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.. British journal of haematology. 119(3):740-50. Abstract
Mielcarek M, Sandmaier BM, Maloney DG, Maris M, McSweeney PA, Woolfrey A, Chauncey T, Feinstein L, Niederwieser D, Blume KG et al..  2002.  Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives.. Journal of clinical immunology. 22(2):70-4. Abstract
Mielcarek M, Torok-Storb B, Storb R.  2002.  ABO incompatibility and relapse risk in patients undergoing allogeneic marrow transplantation for acute myeloid leukemia.. Bone marrow transplantation. 30(8):547-8;authorreply548.
2003
Mielcarek M, Storb R.  2003.  Non-myeloablative hematopoietic cell transplantation as immunotherapy for hematologic malignancies.. Cancer treatment reviews. 29(4):283-90. Abstract
Mielcarek M, Martin PJ, Leisenring W, Flowers MED, Maloney DG, Sandmaier BM, Maris MB, Storb R.  2003.  Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.. Blood. 102(2):756-62. Abstract
2004
Yusuf U, Frangoul HA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG, Deeg HJ, Appelbaum FR, Anasetti C, Storb R et al..  2004.  Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience.. Bone marrow transplantation. 33(8):805-14. Abstract
Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C, Maloney DG, Storb R.  2004.  Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.. Blood. 104(4):961-8. Abstract
Mielcarek M, Martin PJ, Heimfeld S, Storb R, Torok-Storb B.  2004.  CD34 cell dose and chronic graft-versus-host disease after human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.. Leukemia & lymphoma. 45(1):27-34. Abstract
Diaconescu R, Flowers CR, Storer B, Sorror ML, Maris MB, Maloney DG, Sandmaier BM, Storb R.  2004.  Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.. Blood. 104(5):1550-8. Abstract
2005
Burroughs L, Mielcarek M, Little M-T, Bridger G, Macfarland R, Fricker S, Labrecque J, Sandmaier BM, Storb R.  2005.  Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model.. Blood. 106(12):4002-8. Abstract
Sorror ML, Leisenring W, Deeg HJ, Martin PJ, Storb R.  2005.  Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 11(7):567-8.